1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Ascites, Malignant: new trials by email Literature Review of Ascites, Malignant trials Research Report on Ascites, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites zoledronic acid plus Sintilimab intraperitoneal injection - Cancer of Stomach, Adenocarcinoma, Ascites, Malignant | Phase 1 / Phase 2 | Recruiting | Qilu Hospital of Shandong University | 24 | 2024-09-12 | 2025-11-19 |
| Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion, Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected - Gastric Cancer, Peritoneal Metastases | Phase 2 | Unknown | Zhejiang Cancer Hospital | 35 | 2023-03-01 | 2023-09-21 |
Ascites (2) · Stomach Neoplasms (2) · Adenocarcinoma (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Stomach Diseases (2) · Carcinoma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Blood Specimen Collection (1) · Zoledronic Acid (1) · sintilimab (1)
Qilu Hospital of Shandong University (1) · Zhejiang Cancer Hospital (1)
China (2)
Jieer Ying, Dr (1)